Drug Product Defects
Drugs will be subjected to a visual inspection before being
dispensed. Any medication which appears suspicious due to
discrepancy in color, shape, or appearance will not be
If the clinical person preparing to dispense the drug
believes that a drug has been mis-packaged or mis-labeled,
this medication will not be given.
1. Any drug which appears to be defective will be removed
from stock for possible return to the manufacturer or for
2. Problems with drug quality, strength, purity, packaging
and/or labeling will similarly be removed from stock.
3. Therapeutic failures, bioinequivalence and tampering will
be returned to the manufacturer.
4. A general notice will be issued to the Provider Staff
whenever a drug is discovered to be defective; should the
possibility exist that a defective drug has been
administered to any patient, the attending physician will
be notified immediately so that the patient can be
observed for possible drug reaction.
Approved By Governing Board